Fundamental Analysis Of Sun Pharma – Financials & More Details
Trade Brains
JUNE 3, 2023
These divisions have been arranged geographically and the company has a different product portfolio across these divisions. Sun Pharma in-licensed and commercialised an anti-acne product in the US market. We’ll read more about this in the next section of our fundamental analysis of Sun Pharma. making it a leader in the chronic segment.
Let's personalize your content